Thiazolidin-4-one derivatives

A pharmaceutical composition containing at least one thiazolidin-4-one derivative of the Formula (I)

• wherein:
• R1 represents a phenyl group independently mono-, di- or trisubstituted with lower alkyl, halogen, lower alkoxy, or —CF3;
• R2 represents lower alkyl;
• allyl;
• cyclopropyl;
• cyclobutyl;
• cyclopentyl;
• or mono- or di-lower alkylamino;
• R3 represents —O—CR7R8—CR9R10—(CR11R12)n—O—R13;
• R4 represents hydrogen;
• hydroxy;
• lower alkoxy;
• lower alkyl;
• or halogen;
• R5 and R6 each represents independently lower alkyl;
• R7 represents hydrogen, lower alkyl, or hydroxymethyl;
• R8, R9, R11 and R12 each represents independently hydrogen or methyl;
• R10 represents hydrogen or lower alkyl;
• in case n represents the integer 1, R10 in addition represents lower alkoxy, hydroxy, —NH2, —NHR5 or —NR5R6;
• R13 represents hydrogen;
• lower alkyl;
• hydroxycarbonyl-lower lower alkyl;
• 1-glyceryl or 2-glyceryl;
• n represents the integer 0 or 1;
• or configurational isomers, optically pure enantiomers, mixtures of enantiomers, enantiomeric racemates, diastereomers, mixtures of diastereomers, diastereomeric racemates, mixtures of diastereomeric racemates, or a meso-form thereof, or pharmaceutically acceptable salts thereof, and inert carrier material.